Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Review

Do patients with submassive pulmonary embolism benefit from thrombolytic therapy?

Ali Ataya, MD, Jessica Cope, PharmD, Abbas Shahmohammadi, MD and Hassan Alnuaimat, MD
Cleveland Clinic Journal of Medicine December 2016, 83 (12) 923-932; DOI: https://doi.org/10.3949/ccjm.83a.15116
Ali Ataya
Pulmonary Hypertension Program, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Jessica Cope
Pulmonary Hypertension Program, Department of Pharmacy, University of Florida, Gainesville
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abbas Shahmohammadi
Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hassan Alnuaimat
Pulmonary Hypertension Program, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 83 no. 12 923-932
DOI 
https://doi.org/10.3949/ccjm.83a.15116
PubMed 
27938515

Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online December 1, 2016.

Copyright & Usage 
Copyright © 2016 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Ali Ataya, MD⇑
  1. Pulmonary Hypertension Program, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville
  1. ADDRESS:
    Ali Ataya, MD, Pulmonary Hypertension Program, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, 1600 SWArcher Road, M452, PO Box 100225, Gainesville, FL 32610; aliataya{at}gmail.com
  1. Jessica Cope, PharmD
  1. Pulmonary Hypertension Program, Department of Pharmacy, University of Florida, Gainesville
  1. Abbas Shahmohammadi, MD
  1. Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville
  1. Hassan Alnuaimat, MD
  1. Pulmonary Hypertension Program, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville

Cited By...

  • 4 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 83 (12)
Cleveland Clinic Journal of Medicine
Vol. 83, Issue 12
1 Dec 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Do patients with submassive pulmonary embolism benefit from thrombolytic therapy?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Do patients with submassive pulmonary embolism benefit from thrombolytic therapy?
Ali Ataya, Jessica Cope, Abbas Shahmohammadi, Hassan Alnuaimat
Cleveland Clinic Journal of Medicine Dec 2016, 83 (12) 923-932; DOI: 10.3949/ccjm.83a.15116

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Do patients with submassive pulmonary embolism benefit from thrombolytic therapy?
Ali Ataya, Jessica Cope, Abbas Shahmohammadi, Hassan Alnuaimat
Cleveland Clinic Journal of Medicine Dec 2016, 83 (12) 923-932; DOI: 10.3949/ccjm.83a.15116
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • THREE CATEGORIES OF RISK
    • DIAGNOSING SUBMASSIVE PULMONARY EMBOLISM, DELINEATING ITS SEVERITY
    • THROMBOLYTIC AGENTS
    • MAJOR STUDIES IN SUBMASSIVE PULMONARY EMBOLISM
    • SURGICAL EMBOLECTOMY: STILL THE LAST RESORT
    • ONE TREATMENT DOES NOT FIT ALL
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • Thrombolysis in submassive pulmonary embolism: Finding the balance
  • PubMed
  • Google Scholar

Cited By...

  • In reply: Submassive pulmonary embolism (December 2016)
  • Submassive pulmonary embolism (December 2016)
  • Thrombolysis in submassive pulmonary embolism: Finding the balance
  • Google Scholar

More in this TOC Section

  • Alpha-gal syndrome: Recognizing and managing a tick-bite–related meat allergy
  • Managing right ventricular failure in the setting of pulmonary embolism
  • Psychedelics, spirituality, and existential distress in patients at the end of life
Show more Review

Similar Articles

Subjects

  • Emergency Medicine
  • Pulmonology
  • Vascular Medicine

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire